Cibus, Inc. (NASDAQ:CBUS – Get Free Report) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 2,230,000 shares, a growth of 8.8% from the November 30th total of 2,050,000 shares. Based on an average daily volume of 168,500 shares, the short-interest ratio is presently 13.2 days. Approximately 11.9% of the company’s shares are sold short.
Institutional Investors Weigh In On Cibus
Several large investors have recently bought and sold shares of the stock. SG Americas Securities LLC purchased a new stake in shares of Cibus during the third quarter worth approximately $33,000. B. Riley Wealth Advisors Inc. acquired a new position in Cibus during the 3rd quarter worth approximately $44,000. Virtu Financial LLC purchased a new stake in shares of Cibus in the 3rd quarter valued at approximately $48,000. HighTower Advisors LLC raised its holdings in shares of Cibus by 20.6% in the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after purchasing an additional 2,750 shares in the last quarter. Finally, Barclays PLC raised its holdings in shares of Cibus by 287.2% in the 3rd quarter. Barclays PLC now owns 20,269 shares of the company’s stock valued at $66,000 after purchasing an additional 15,034 shares in the last quarter. Hedge funds and other institutional investors own 33.81% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Cibus in a research note on Tuesday, October 22nd. HC Wainwright reaffirmed a “buy” rating and issued a $25.00 target price on shares of Cibus in a research report on Monday, November 11th. Finally, Alliance Global Partners reduced their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research report on Tuesday, September 24th.
Cibus Stock Performance
Shares of Cibus stock traded up $0.20 during trading hours on Wednesday, reaching $2.78. 307,747 shares of the company were exchanged, compared to its average volume of 141,768. The firm has a market cap of $73.55 million, a PE ratio of -0.12 and a beta of 1.86. Cibus has a 1 year low of $2.35 and a 1 year high of $23.18. The stock’s fifty day moving average is $4.01 and its 200 day moving average is $5.81.
Cibus Company Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Further Reading
- Five stocks we like better than Cibus
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Work and Play: Investing in the Rise of Bleisure Travel
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Using the MarketBeat Dividend Tax Calculator
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.